Pregnancy
category N/A Legal status Withdrawn PubChem CID 60919 | ATC code C09CA05 (WHO) CAS Number 145733-36-4 IUPHAR/BPS 6898 | |
 | ||
How to pronounce tasosartan
Tasosartan is an angiotensin II receptor antagonist.
It was withdrawn from FDA review by the manufacturer after phase III clinical trials showed elevated transaminases (a sign of possible liver toxicity) in a significant number of participants given the drug.
References
Tasosartan Wikipedia(Text) CC BY-SA